Stockscreener 앱 받기
24.64
4.05%
0.96
시간 외 거래:
24.28
-0.36
-1.46%
전일 마감가:
$23.68
열려 있는:
$23.68
하루 거래량:
108.32K
Relative Volume:
2.42
시가총액:
$44.04M
수익:
$24.05M
순이익/손실:
$-363.00K
주가수익비율:
-83.55
EPS:
-0.2949
순현금흐름:
$359.00K
1주 성능:
+3.53%
1개월 성능:
+10.20%
6개월 성능:
+4.85%
1년 성능:
+73.64%
1일 변동 폭
$23.10
$24.64
1주일 범위
$22.60
$25.79
52주 변동 폭
$13.02
$33.63
Precipio Inc Stock (PRPO) Company Profile
명칭
Precipio Inc
전화
203 787 7888
주소
4 SCIENCE PARK, NEW HAVEN, CT
Compare PRPO vs TMO, DHR, IDXX, NTRA, A
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PRPO
Precipio Inc
|
24.64 | 42.32M | 24.05M | -363.00K | 359.00K | -0.2949 |
TMO
Thermo Fisher Scientific Inc
|
532.48 | 201.86B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
203.83 | 145.10B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
567.44 | 45.44B | 4.45B | 1.10B | 1.06B | 13.59 |
NTRA
Natera Inc
|
271.39 | 38.64B | 2.50B | -226.32M | 71.51M | -1.6412 |
A
Agilent Technologies Inc
|
131.46 | 38.44B | 7.23B | 1.41B | 1.09B | 4.979 |
Precipio Inc 주식(PRPO)의 최신 뉴스
Form 4 Precipio Inc For: 16 July By Investing.com - Investing.com Canada
Precipio (PRPO) director receives 108-share stock grant for Q2-26 service - Stock Titan
Precipio, Inc. (PRPO) director gets 416-share stock grant for Q2 board fees - Stock Titan
Precipio, Inc. (PRPO) director takes stock in lieu of cash pay - Stock Titan
PRPO vs. NEO: Which Cancer Diagnostics Stock Is the Better Buy? - The Globe and Mail
Liquidity Mapping Around (PRPO) Price Events - Stock Traders Daily
Why (PRPO) Price Action Is Critical for Tactical Trading - Stock Traders Daily
The Zacks Analyst Blog Highlights Caterpillar, Palo Alto Networks, Toyota Motor and Precipio - Yahoo Finance
Precipio, Inc.(NasdaqCM: PRPO) added to Russell 3000E Index - marketscreener.com
Precipio, Inc.(NasdaqCM: PRPO) added to Russell Microcap Index - marketscreener.com
Precipio, Inc.(NasdaqCM: PRPO) added to Russell 3000E Growth Benchmark - marketscreener.com
Precipio, Inc.(NasdaqCM: PRPO) added to Russell Microcap Growth Benchmark Index - marketscreener.com
Precipio Inc. (PRPO) Surges Past Key Resistance Level on Strong MomentumBull Pennant - dars.gov.et
Precipio Inc. (PRPO) Q2 2025 Earnings: Positive EPS of $0.05 Marks a MilestoneEBITDA Margin Trends - dars.gov.et
Price to sales forward of Precipio, Inc. – NASDAQ:PRPO - TradingView
Enterprise value to EBITDA forward of Precipio, Inc. – NASDAQ:PRPO - TradingView
Enterprise value to revenue forward of Precipio, Inc. – NASDAQ:PRPO - TradingView
Precipio Is Requesting Shareholders/Brokers Vote Today to Avoid Costly Adjournment and Rescheduling of Annual Shareholders Meeting - Moomoo
Precipio, Inc. Actuals & Estimates (NASDAQ:PRPO) - TradingView
PRPO Q2 2025 Earnings: Positive Earnings per Share Signal TurnaroundBanking Earnings Report - DonanımHaber
Precipio Inc. (PRPO) Q2 2025 Earnings: Positive EPS of $0.05 Amidst Data Gaps; Stock DeclinesEPS Consistency Score - dars.gov.et
Understanding Momentum Shifts in (PRPO) - Stock Traders Daily
PRPO Q2 2025 Earnings: Positive EPS Achieved Amid Disclosed Revenue ReductionQuarterly Profit Report - DonanımHaber
Precipio Inc (PRPO) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Precipio Inc (PRPO) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Precipio Inc (PRPO) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Precipio Inc (PRPO) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Precipio Inc (PRPO) Institutional Confidence - TradingKey
Precipio Inc (PRPO) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Precipio Inc (PRPO) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Precipio Inc (PRPO) Valuation: PE, PB & Fair Value Analysis - TradingKey
Precipio Inc (PRPO) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
PRPO: Rapid, profitable growth driven by innovative four-hour cancer diagnostics and scalable operations - TradingView
PRPO: Rapid, profitable growth driven by innovative diagnostics and strong customer retention - TradingView
Precipio (PRPO) AGM 2026 Summary - Quartr
Precipio Shareholders Back Board Nominees and Auditor - TipRanks
[8-K] Precipio, Inc. Reports Material Event - Stock Titan
Precipio to Present at the Planet MicroCap Las Vegas - The National Law Review
Precipio Inc Annual Shareholders Meeting Transcript - GuruFocus
Precipio Inc. (PRPO) Q2 2025 Earnings: Positive EPS Achieved Amid Stock DeclineEBITDA Analysis - newsline.com
Precipio is requesting Shareholders/Brokers vote today to avoid costly adjournment and rescheduling of Annual Shareholders Meeting - The Manila Times
Precipio urges shareholders to vote ahead of Saturday meeting - Investing.com
Precipio urges shareholders to vote ahead of Saturday meeting By Investing.com - Investing.com Australia
Lack of quorum may force costly delay of Precipio shareholder meeting - Stock Titan
Cancer diagnostics firm Precipio heads to Vegas for Planet MicroCap 2026 - Stock Titan
Precipio to present at Planet MicroCap Las Vega... - Pluang
Avoiding Lag: Real-Time Signals in (PRPO) Movement - Stock Traders Daily
Precipio Inc. (PRPO) Edges Higher Amid Consolidation Near ResistanceShort Setup Alerts - newsline.com
Precipio Inc. (PRPO) Edges Higher as Stock Nears ResistanceSell Signal Alerts - newsline.com
Precipio (PRPO) Q1 2026 Earnings Call Transcript - AOL.com
Precipio Q2 2025 Earnings: Positive EPS Marks a Milestone Despite Market ReactionMargin Compression Risk - newsline.com
Precipio Inc (PRPO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.61%
1.88%
자본화:
|
볼륨(24시간):